Bimonthly, Established in 1959
Open access journal

Innovations in Schizophrenia Treatment: Emerging Therapies and Holistic Approaches

Schizophrenia remains one of the most complex and challenging mental health disorders to manage effectively. This article compiles recent scholarly works that explore innovative and integrated approaches to treating schizophrenia, ranging from pharmacological advancements to cognitive behavioral therapies. Through a review of current treatment strategies and emerging agents, we aim to highlight the multifaceted nature of schizophrenia management and the promise of newer, more effective treatments.

  • Title: An Update on Current Treatment Strategies and Emerging Agents for the Management of Schizophrenia

    Authors: Megan Maroney

    Description: This article reviews the current landscape and future directions of pharmacological treatments for schizophrenia, highlighting emerging agents such as Roluperidone and TAAR-1 agonists like SEP-363856. These new treatments aim to address both the negative symptoms and cognitive dysfunctions often associated with schizophrenia, offering hope for more comprehensive management strategies​ (AJMC)​.

  • Title: Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment

    Authors: Pronab Ganguly, Abdrabo SolimanAbdrabo Soliman, Ahmed A. Moustafa,Ahmed A. Moustafa1

    Description: This review emphasizes a holistic approach to managing schizophrenia, incorporating both pharmacological treatments and non-pharmacological methods. It discusses the integration of medications with other therapies to improve overall patient outcomes and enhance quality of life, underlining the importance of early diagnosis and tailored treatment plans​ (Frontiers)​.

  • Title: Cognitive Behavioural Therapy for schizophrenia – outcomes for functioning, distress and quality of life: a meta-analysis

    Authors: Keith R. Laws, Nicole Darlington, Tejinder K. Kondel, Peter J. McKenna & Sameer Jauhar

    Description: This meta-analysis examines the effectiveness of Cognitive Behavioural Therapy (CBT) for patients with schizophrenia, focusing on its impact on functioning, distress, and quality of life. The study consolidates data from various trials, highlighting the positive outcomes CBT can provide in the management of schizophrenia, especially when combined with other treatment modalities​ (BioMed Central)​.